How do I buy Madrigal Pharmaceuticals (MDGL) stock?

You can purchase shares of Madrigal Pharmaceuticals (NASDAQ:MDGL) through any online brokerage.View our list of the best stock brokerages

Who are Madrigal Pharmaceuticals (MDGL) competitors?

Other companies in Madrigal Pharmaceuticals’s space includes: Avidity Biosciences Inc (NASDAQ:RNA), Exact Sciences Corp (NASDAQ:EXAS), Neurocrine Biosciences Inc (NASDAQ:NBIX), Ionis Pharmaceuticals Inc (NASDAQ:IONS) and Roivant Sciences Ltd (NASDAQ:ROIV).

What is the forecast, or price target, for Madrigal Pharmaceuticals (MDGL) stock?

Madrigal Pharmaceuticals has a consensus price target of $548.56.

What is the current price for Madrigal Pharmaceuticals (MDGL)?

The stock price for Madrigal Pharmaceuticals (NASDAQ: MDGL) is $501.68 last updated January 16, 2026 at 4:00 PM EST.

Does Madrigal Pharmaceuticals (MDGL) pay a dividend?

There are no upcoming dividends for Madrigal Pharmaceuticals.

When is Madrigal Pharmaceuticals (NASDAQ:MDGL) reporting earnings?

Madrigal Pharmaceuticals does not have any upcoming earnings scheduled.

Is Madrigal Pharmaceuticals (MDGL) going to split?

There is no upcoming split for Madrigal Pharmaceuticals.

What sector and industry does Madrigal Pharmaceuticals (MDGL) operate in?

Madrigal Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Madrigal Pharmaceuticals (MDGL) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver f...

Comments